Page last updated: 2024-11-06

hydroxyproline and Gaucher Disease

hydroxyproline has been researched along with Gaucher Disease in 1 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Gaucher Disease: An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (GLUCOSYLCERAMIDASE) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the MONONUCLEAR PHAGOCYTE SYSTEM. The characteristic Gaucher cells, glycosphingolipid-filled HISTIOCYTES, displace normal cells in BONE MARROW and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciana, G1
Martini, C1
Leopaldi, A1
Tamaro, G1
Katouzian, F1
Ronfani, L1
Bembi, B1

Other Studies

1 other study available for hydroxyproline and Gaucher Disease

ArticleYear
Bone marker alterations in patients with type 1 Gaucher disease.
    Calcified tissue international, 2003, Volume: 72, Issue:3

    Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density; Bone Rem

2003